167 related articles for article (PubMed ID: 32386871)
1. Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status.
Farrell MH; La Pean Kirschner A; Tluczek A; Farrell PM
J Pediatr; 2020 Sep; 224():37-43.e2. PubMed ID: 32386871
[TBL] [Abstract][Full Text] [Related]
2. Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell.
Farrell MH; Sims AM; La Pean Kirschner A; Farrell PM; Tarini BA
J Pediatr; 2020 Sep; 224():44-50.e1. PubMed ID: 32826027
[TBL] [Abstract][Full Text] [Related]
3. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
Kai J; Ulph F; Cullinan T; Qureshi N
Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
[TBL] [Abstract][Full Text] [Related]
4. Parents' Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease.
Chudleigh J; Buckingham S; Dignan J; O'Driscoll S; Johnson K; Rees D; Wyatt H; Metcalfe A
J Genet Couns; 2016 Dec; 25(6):1215-1226. PubMed ID: 27098418
[TBL] [Abstract][Full Text] [Related]
5. Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathy.
Collins JL; La Pean A; O'Tool F; Eskra KL; Roedl SJ; Tluczek A; Farrell MH
Patient Educ Couns; 2013 Mar; 90(3):378-85. PubMed ID: 22240007
[TBL] [Abstract][Full Text] [Related]
6. Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening.
Ulph F; Cullinan T; Qureshi N; Kai J
Eur J Hum Genet; 2015 Apr; 23(4):459-65. PubMed ID: 25005733
[TBL] [Abstract][Full Text] [Related]
7. A qualitative secondary evaluation of statewide follow-up interviews for abnormal newborn screening results for cystic fibrosis and sickle cell hemoglobinopathy.
La Pean A; Collins JL; Christopher SA; Eskra KL; Roedl SJ; Tluczek A; Farrell MH
Genet Med; 2012 Feb; 14(2):207-14. PubMed ID: 22261754
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell and cystic fibrosis carrier results.
Nurs Child Young People; 2016 Oct; 28(8):21. PubMed ID: 27712319
[TBL] [Abstract][Full Text] [Related]
9. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
[TBL] [Abstract][Full Text] [Related]
10. Improving communication between doctors and parents after newborn screening.
Farrell MH; Christopher SA; Tluczek A; Kennedy-Parker K; La Pean A; Eskra K; Collins J; Hoffman G; Panepinto J; Farrell PM
WMJ; 2011 Oct; 110(5):221-7. PubMed ID: 22164579
[TBL] [Abstract][Full Text] [Related]
11. Frequency of high-quality communication behaviors used by primary care providers of heterozygous infants after newborn screening.
Farrell MH; Christopher SA
Patient Educ Couns; 2013 Feb; 90(2):226-32. PubMed ID: 23194821
[TBL] [Abstract][Full Text] [Related]
12. Initially misleading communication of carrier results after newborn genetic screening.
La Pean A; Farrell MH
Pediatrics; 2005 Dec; 116(6):1499-505. PubMed ID: 16322177
[TBL] [Abstract][Full Text] [Related]
13. Disclosing to parents newborn carrier status identified by routine blood spot screening.
Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
[TBL] [Abstract][Full Text] [Related]
14. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis.
Lang CW; Stark AP; Acharya K; Ross LF
Am J Med Genet A; 2009 Nov; 149A(11):2424-9. PubMed ID: 19876910
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the effects of disclosing carrier results generated through newborn screening.
Hayeems RZ; Bytautas JP; Miller FA
J Genet Couns; 2008 Dec; 17(6):538-49. PubMed ID: 18956236
[TBL] [Abstract][Full Text] [Related]
16. A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis.
Stark AP; Lang CW; Ross LF
Am J Perinatol; 2011 Mar; 28(3):169-76. PubMed ID: 20830657
[TBL] [Abstract][Full Text] [Related]
17. Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges.
Parker H; Qureshi N; Ulph F; Kai J
BMC Health Serv Res; 2007 Dec; 7():203. PubMed ID: 18078504
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening: an appeal for improved parent education.
Tluczek A; Orland KM; Nick SW; Brown RL
J Perinat Neonatal Nurs; 2009; 23(4):326-34. PubMed ID: 19915416
[TBL] [Abstract][Full Text] [Related]
19. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
Lewis S; Curnow L; Ross M; Massie J
J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
Tluczek A; Koscik RL; Farrell PM; Rock MJ
Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
